Back
Tilray Brands Vs. Acasti Pharma Industry Stock Comparison
Sell
28
TLRY
Tilray Brands
Last Price:
1.94
Seasonality Move:
5.28%
Buy
55
ACST
Acasti Pharma
Last Price:
2.79
Seasonality Move:
19.61%
Sell
28
Tilray Brands (TLRY)
is a Sell
Is Tilray Brands a Buy, Sell or Hold?
- The current Tilray Brands [TLRY] share price is $1.95. The Score for TLRY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- TLRY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Acasti Pharma (ACST)
is a Buy
Is Acasti Pharma a Buy, Sell or Hold?
- The current Acasti Pharma [ACST] share price is $2.89. The Score for ACST is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ACST is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TLRY Stock Price Chart
What is Tilray Brands's stock price today?
-
The Tilray Brands share price today is $1.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TLRY is experiencing slight selling pressure.
ACST Stock Price Chart
What is Acasti Pharma's stock price today?
-
The Acasti Pharma share price today is $2.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACST is experiencing buying pressure, which is a positive indicator for future bullish movement.
TLRY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 48.77 | Sell |
| Chaikin Money Flow: | -7223586 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.7 - 2.28) | Sell |
| Bollinger Bands (100): | (1.73 - 2.25) | Sell |
ACST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 41.34 | Sell |
| Chaikin Money Flow: | 15732 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.83 - 3.33) | Sell |
| Bollinger Bands (100): | (2.49 - 3.37) | Sell |
TLRY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.05 | Sell |
| 20-day SMA: | 1.89 | Buy |
| 50-day SMA: | 1.98 | Sell |
| 200-day SMA: | 2.1 | Sell |
| 8-day EMA: | 1.99 | Sell |
| 20-day EMA: | 1.98 | Sell |
| 50-day EMA: | 1.98 | Sell |
| 200-day EMA: | 2.12 | Sell |
ACST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.87 | Buy |
| 20-day SMA: | 3 | Sell |
| 50-day SMA: | 3.24 | Sell |
| 200-day SMA: | 2.62 | Buy |
| 8-day EMA: | 2.9 | Sell |
| 20-day EMA: | 3 | Sell |
| 50-day EMA: | 3.07 | Sell |
| 200-day EMA: | 2.92 | Sell |
Tilray Brands Earnings Growth & TLRY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.78 per share, and an increase next year of $0.06 per share.
Acasti Pharma Earnings Growth & ACST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.07 per share, an increase this year of $1.16 per share, and an increase next year of $0.34 per share.
Tilray Brands Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Acasti Pharma Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||